Skip to main content

United States News All stories

Every story in this section, newest first — page 328 of 373.

Grafa
Health

Intuitive Surgical surpasses $10B revenue Milestone as da Vinci 5 Adoption Accelerates

Intuitive Surgical (NASDAQ:ISRG) hit a major financial landmark Wednesday, reporting preliminary 2025 revenue of $10.06 billion, a 21% increase over the prior year.

The results, fueled by the rapid rollout of the next-generation da Vinci 5 system, underscore the company’s dominant grip on the robotic-assisted surgery market as it transitions from a niche technology provider to a foundational healthcare infrastructure giant.

Read more: Intuitive Surgical surpasses $10B revenue Milestone as da Vinci 5 Adoption Accelerates
Grafa
Technology

GlobalFoundries to acquire Synopsys processor unit in "physical AI" expansion

Synopsys (NASDAQ:SNPS) has reached a definitive agreement to sell its Processor IP Solutions business to GlobalFoundries (NASDAQ:GFS), a strategic divestiture that signals a narrowing of focus for the EDA giant toward high-growth interface and foundational silicon IP.

Read more: GlobalFoundries to acquire Synopsys processor unit in "physical AI" expansion
Grafa
Health

Dr. Reddy’s launches first generic "extra strength" allergy eye drop in U.S.

Dr. Reddy’s Laboratories (NYSE:RDY) announced Wednesday the first-to-market launch of its over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution, 0.7%, providing a lower-cost generic equivalent to Alcon’s Extra Strength Pataday® Once-Daily Relief.

Read more: Dr. Reddy’s launches first generic "extra strength" allergy eye drop in U.S.
Grafa

Citigroup profit surpasses estimates as dealmaking rebound offsets Russia exit loss

Citigroup (NYSE:C) reported fourth-quarter adjusted earnings that comfortably beat Wall Street expectations, as a resurgence in investment banking and the steady performance of its "crown jewel" services unit helped the bank weather a massive charge related to its exit from Russia.

Read more: Citigroup profit surpasses estimates as dealmaking rebound offsets Russia exit loss
Grafa
Technology

Diginex closes €55 million acquisition of Plan A to create ESG technology powerhouse

Diginex (NASDAQ:DGNX) finalized its acquisition of PlanA.earth GmbH on Wednesday, a transformative move that consolidates two of Europe’s leading sustainability platforms into a single, integrated "RegTech" giant.

Read more: Diginex closes €55 million acquisition of Plan A to create ESG technology powerhouse
Grafa
Health

Emergent BioSolutions wins FDA nod for discreet NARCAN carrying case to boost daily readiness

Emergent BioSolutions (NYSE:EBS) received FDA approval Wednesday for a redesigned, compact carrying case for its over-the-counter (OTC) NARCAN® Nasal Spray, a move aimed at overcoming the "stigma of carrying" that has long hampered community-level overdose responses.

Read more: Emergent BioSolutions wins FDA nod for discreet NARCAN carrying case to boost daily readiness
Grafa
Technology

Rail Vision acquires majority stake in Quantum Transportation to fuel AI-rail synergies

Rail Vision (NASDAQ:RVSN) announced Wednesday it has finalized the acquisition of a 51% ownership interest in Quantum Transportation, a strategic move that integrates cutting-edge quantum computing into the company’s suite of railway safety and autonomous driving technologies.

Read more: Rail Vision acquires majority stake in Quantum Transportation to fuel AI-rail synergies
Grafa

United Community Banks surges on record 2025 revenue and margin expansion

United Community Banks (NYSE:UCB) capped a historic 2025 on Wednesday, reporting record full-year revenue of $1.063 billion as the Greenville-based regional lender successfully navigated a volatile interest rate environment to deliver double-digit earnings growth.

Read more: United Community Banks surges on record 2025 revenue and margin expansion
Grafa
Health

NRx Pharmaceuticals submits landmark 70,000-patient data to FDA for suicide-prevention breakthrough

NRx Pharmaceuticals (NASDAQ:NRXP) achieved a pivotal regulatory milestone Wednesday, announcing the submission of a massive real-world dataset to the U.S. Food and Drug Administration (FDA) to support the accelerated approval of NRX-100, its proprietary preservative-free ketamine.

Read more: NRx Pharmaceuticals submits landmark 70,000-patient data to FDA for suicide-prevention breakthrough
Grafa

Wells Fargo profits climb to $5.4B as lending gains offset real estate stress

Wells Fargo & Co. (NYSE:WFC) reported fourth-quarter net income of $5.4 billion, or $1.62 per diluted share, as the bank successfully leveraged higher loan balances and a surge in wealth management fees to overcome persistent headwinds in its commercial real estate portfolio.

Read more: Wells Fargo profits climb to $5.4B as lending gains offset real estate stress
Grafa
Technology

Infosys raises outlook as AI deals drive Q3 earnings beat

Infosys (NYSE:INFY) raised its full-year revenue forecast on Wednesday after reporting third-quarter results that surpassed Wall Street expectations, signaling a resilient recovery in enterprise technology spending.

The Bangalore-based outsourcing giant now expects revenue to grow between 3% and 3.5% for the fiscal year ending March 2026, up from its previous projection of 2% to 3%.

For the quarter ended December 31, 2025, Infosys reported net profit of $747 million, or 18 cents per share.

On an adjusted basis, earnings reached 21 cents per share, topping the 20-cent average estimate from analysts surveyed by Zacks Investment Research.

Revenue rose to $5.1 billion, exceeding the $5.08 billion forecast by the Street.

The upgraded guidance reflects a surge in demand for the company’s "AI-first" services, specifically its Topaz generative AI platform.

Infosys reported a large deal total contract value (TCV) of $4.8 billion for the quarter, with "net new" deals accounting for 57% of that figure.

Despite seasonal headwinds like winter furloughs in the U.S. and Europe, the company managed to maintain stable operating margins between 20% and 22%.

The results come as a relief to the broader Indian IT sector, which has faced concerns over sluggish discretionary spending.

While profit dipped 2% year-over-year in rupee terms due to the impact of new labor codes in India, the sequential improvement in margins and the volume of new deals suggest that the sector’s "winter of discontent" may be thawing.

Read more: Infosys raises outlook as AI deals drive Q3 earnings beat
Grafa
Mining

Triple Flag hits record revenue as gold prices surge to new 2026 highs

Triple Flag Precious Metals Corp. (NYSE:TFPM) delivered its ninth consecutive year of growth on Wednesday, reporting record annual revenue of $388.7 million as a historic rally in gold and silver prices boosted the value of its streaming and royalty portfolio.

Read more: Triple Flag hits record revenue as gold prices surge to new 2026 highs
Grafa
Technology

Xpeng targets 600,000 deliveries as pivot to "physical AI" gains momentum

Xpeng (NYSE:XPEV) has set an internal delivery target of up to 600,000 vehicles for 2026, according to people familiar with the matter, as the Volkswagen-backed automaker transitions from a traditional car manufacturer into a "physical AI" powerhouse.

Read more: Xpeng targets 600,000 deliveries as pivot to "physical AI" gains momentum